MEDA-4 inhibitors are a specialized class of chemical compounds, aiming at targeting the MEDA-4 component of the larger Mediator complex, a multi-protein assembly integral to the regulation of gene transcription in eukaryotic cells. MEDA-4, also known as Mediator of RNA polymerase II transcription subunit 4, plays a key role within this complex, orchestrating the interactions between different subunits and ensuring a coordinated response in gene expression mechanisms. Thus, compounds that can effectively inhibit MEDA-4 have the potential to significantly influence the dynamics of gene transcription by modulating the Mediator complex's activity.
The design and development of MEDA-4 inhibitors demand a profound understanding of the structural and functional aspects of the protein. Historically, many inhibitors targeting components of the Mediator complex have been found in natural products, while others have been synthetically produced based on the molecular intricacies of their targets. In the case of MEDA-4, the binding pockets, protein-protein interaction regions, and any allosteric sites serve as critical regions of interest. Potential inhibitors may interact with these domains, disrupting the protein's natural function or its interactions within the Mediator complex. The chemical diversity within this class of inhibitors can range from small molecule inhibitors, which can snugly fit into the protein's active or binding sites, to larger molecules that might target multiple facets of the protein's structure. As with any inhibitor targeting a specific protein, specificity and selectivity are paramount, ensuring that the compound effectively modulates MEDA-4 without substantial off-target effects.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide inhibits RNA polymerase II. Given MEDA-4's role in transcription, this compound might affect MEDA-4's function within the Mediator complex. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
By binding DNA and disrupting transcription, Actinomycin D might indirectly alter the operational dynamics of MEDA-4 in the transcriptional process. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
As an inhibitor of RNA polymerase II, DRB could theoretically influence MEDA-4's mediation in the transcription process by modifying the overall transcriptional environment. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
By inhibiting RNA polymerase II, α-Amanitin could potentially impact the functional role of MEDA-4 in transcription initiation and elongation. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
A CDK inhibitor, Flavopiridol could indirectly influence the Mediator complex and potentially modify MEDA-4's interactions with other subunits in the complex. | ||||||
KPT 330 | 1393477-72-9 | sc-489062 | 5 mg | $170.00 | ||
By inhibiting the nuclear export of transcription factors, Selinexor might indirectly modulate MEDA-4's functional dynamics in the nucleus. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1's bromodomain inhibition could affect transcription-associated proteins, potentially impacting MEDA-4's interactions and function within the Mediator complex. | ||||||
GSK 525762A | 1260907-17-2 | sc-490339 sc-490339A sc-490339B sc-490339C sc-490339D | 5 mg 10 mg 50 mg 100 mg 1 g | $300.00 $540.00 $940.00 $1680.00 $5900.00 | ||
By inhibiting bromodomains, I-BET762 could theoretically modulate the broader transcriptional landscape where MEDA-4 operates. | ||||||
THZ1 | 1604810-83-4 | sc-507542 | 1 mg | $95.00 | ||
By targeting CDK7 in the Mediator-CDK7 complex, THZ1 could theoretically influence MEDA-4's dynamics and interactions within the complex. | ||||||
AZD1152-HQPA | 722544-51-6 | sc-265334 | 10 mg | $375.00 | ||
As an inhibitor of Aurora B kinase, Barasertib might influence cellular processes, including transcription, which could indirectly affect MEDA-4's role within the Mediator complex. |